SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-011209
Filing Date
2019-06-03
Accepted
2019-06-03 07:10:14
Documents
5
Period of Report
2019-05-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20190530_8k.htm 8-K 34808
2 EXHIBIT 4.1 ex_146212.htm EX-4.1 92050
3 EXHIBIT 10.1 ex_146213.htm EX-10.1 306784
4 EXHIBIT 99.1 ex_146242.htm EX-99.1 11461
5 img.jpg GRAPHIC 11737
  Complete submission text file 0001437749-19-011209.txt   462732
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 19872122
SIC: 2834 Pharmaceutical Preparations